Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2
Author(s) -
Huanhuan Zhao,
Jun Lu,
Yan Tong,
Fei Han,
Jie Sun,
Xiaolin Yin,
Liting Cheng,
Chao Shen,
Mark Wunderlich,
Weina Yun,
Ling–Ling Yang,
Liyun Chen,
Dan Su,
Stefan K. Bohlander,
Fudi Wang,
James C. Mulloy,
Chong Li,
Jianjun Chen,
He Huang,
Xi Jiang
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.110253
Subject(s) - myeloid leukemia , pharmacology , cancer research , opioid receptor , opioid , leukemia , biology , receptor , agonist , chemistry , immunology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom